Tempus AI, Inc. · TEM · Next earnings

Tempus AI, Inc. next earnings report

TEM's next report date is not on the calendar yet. Here is where the last quarter left off and what remains open. Last quarter: Tempus pairs Q3 growth with new partnerships and execution risks

Date not yet scheduled Healthcare

What the street expects

Consensus for the coming report
Consensus EPS — Calendar consensus
Consensus revenue — Calendar consensus
Report date TBD Not yet on the calendar
Session — Session not yet known

Where TEM left off: FY2026 Q3

Full report

Tempus pairs Q3 growth with new partnerships and execution risks

EPS surprise — Reported — vs $-0.09
Revenue surprise — Reported — vs $409.4M
Stock move +9.5% Event window
Subsequent drift 0.0% Up to 20 sessions

Management's guidance sentiment was characterized as raised, with 2026 revenue guidance described as $1.6 billion. The supplied analysis does not specify a comparable prior-period figure for this quarter.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Hereditary testing growth may be affected by clinician fee-schedule changes and reimbursement.
  • The timing and magnitude of XT and XF assay pricing changes, as well as XF approval, remain uncertain.
  • Personalis integration, clearance and MRD gross-profit progress remain execution variables.
  • Sustaining EBITDA margin expansion while investing in growth and converting data bookings into durable subscriptions are open questions.
  • Competition in liquid biopsy and MRD markets could pressure execution.

Questions analysts left open

  • Stability of hereditary test growth amid clinician fee-schedule changes.
  • Timing and magnitude of XT and XF assay pricing changes.
  • When Personalis MRD testing may achieve positive gross profit per test.
  • Whether EBITDA margin expansion can continue while the company reinvests for growth.
  • Visibility into data-business bookings and subscription renewals.

Ask FN2 about TEM next report

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the TEM recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent TEM quarters

All TEM earnings

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.